Lu AF28996 for Parkinson's Disease Motor Fluctuations
Part of Brain & nervous system clinical trials.
This trial tests a new medication called Lu AF28996 to help reduce the periods when Parkinson's symptoms worsen throughout the day (called 'OFF times'). If you have motor fluctuations that are predictable and affecting your daily life, this study might help you experience fewer of these difficult periods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with Parkinson's disease at least 3 years ago, after age 30
- Experience noticeable, predictable motor fluctuations (OFF times) every day that significantly affect your activities
- Motor fluctuations have been consistent and troubling for at least 3 months
- Cognitive assessment score above 24 (adjusted for education level)
- Not pregnant, breastfeeding, or unwilling to use contraception if of childbearing age
- Not taken any experimental medications in the past 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an injection of a naturally occurring nerve-protective substance called GM1 ganglioside can reduce motor fluctuations (sudden off-periods and unpredictable movement changes) in people with Parkinson's disease who take levodopa. The goal is to help smooth out medication effectiveness throughout the day.
This study looks at a new pump treatment (foslevodopa/foscarbidopa) for people with advanced Parkinson's who are having motor fluctuations. It aims to see if it improves quality of life when started earlier in the advanced stage.
This study tests a new pump-delivered combination of Parkinson's medications (foslevodopa/foscarbidopa) in adults who have recently started having motor fluctuations but are not yet using other device therapies. It aims to see how well it works in real life and may offer better symptom control.
This study tests an investigational drug to see if it can help people with early Parkinson's disease. It may offer a new treatment option to manage symptoms.
This study tests an experimental treatment (LY3962681) for people with early Parkinson's. It aims to see if the treatment is safe and can slow the disease. You must have a confirmed diagnosis, be in good overall health, and have stable medication use.
This trial tests a new injection called UX-DA003 for people with Parkinson's disease whose current medications are becoming less effective. It aims to see if this treatment can help reduce "off" time and improve motor symptoms.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.